Abstract
Edible mushrooms have been classified as “next-generation food” due to their high nutritional value
coupled with their biological and functional potential. The most extensively studied and reported mushroom
macromolecules are polysaccharides. However, macrofungi proteins and peptides are also a representative and
significant bioactive group. Several factors such as species, substrate composition and harvest time significantly
impact the mushroom protein content, typically ranging between 19 and 35% on a dry weight basis. Proteins
work based on their shape and structure. Numerous extraction methods, including chemical and non-conventional,
and their implications on protein yield and stability will be discussed. Beyond their biological potential, a
great advantage of mushroom proteins is their uniqueness, as they often differ from animal, vegetable, and microbial
proteins. According to recently published reports, the most relevant mushroom bioactive proteins and
peptides include lectins, fungal immunomodulatory proteins, ubiquitin-like proteins, and proteins possessing enzymatic
activity such as ribonucleases laccases, and other enzymes and ergothioneine. These are reported as antioxidant,
antiviral, antifungal, antibacterial, antihypertensive, immunomodulatory, antitumour, antihypercholesterolemic
or antihyperlipidemic, antidiabetic and anti-inflammatory properties, which improved proteins and
peptides research interest and contributed to the increase of mushroom market value. This review provides an
overview of the most relevant biochemical and biological properties of the main protein groups in edible mushrooms,
explicitly focusing on their biomedical potential. Although mushrooms are a rich source of various proteins,
many of these molecules have yet to be identified and characterised. Accordingly, it is crucial to identify
and characterise new macromolecules of macrofungi origin, which opens an opportunity for further investigation
to identify new bioactives for food, nutraceutical, or medicinal applications.
Keywords:
Mushrooms, bioactive proteins, protein extraction, lectins, fungal immunomodulatory protein, mushroom enzymes, peptides, ergothioneine, health benefits.
[7]
Cateni F, Gargano ML, Procida G, Venturella G, Cirlincione F, Ferraro V. Mycochemicals in wild and cultivated mushrooms: nutrition and health. Netherlands: Phytochemistry Reviews. Springer 2021; 2.
[14]
Murray JE, Laurieri N, Delgoda R. Proteins Pharmacognosy: Fundamentals, Applications and Strategy. Elsevier Inc. 2017; pp. 477-94.
[35]
Sharif S, Mustafa G, Munir H, Weaver CM, Jamil Y, Shahid M. Proximate composition and micronutrient mineral profile of wild Ganoderma lucidum and four commercial exotic mushrooms by ICP-OES and LIBS. J Food Nutr Res 2016; 4(11): 703-8.
[38]
Kurtzman RH Jr. Mushrooms as a source of food proteins. In: M. Friedman, Ed. Protein Nutritional Quality of foods and feeds: New York, 1975; 2: 305-18.
[40]
Khan MA. Nutritional composition and Hypocholesterolemic effect of mushroom: Pleurotus sajor-caju and Pleurotus florida. Saarbrucken, Germany: LAP Lambert Academic publishing Gmbh &co. KG: Saarbrucken 2010; pp. 1-11.
[53]
Prandi B, di Massimo M, Tedeschi T, Rodríguez-Turienzo L, Rodríguez Ó. Ultrasound and microwave-assisted extraction of proteins from coffee green beans: effects of process variables on the protein integrity. Food Bioproc Tech 2022; 15(12): 2712-2.
[77]
Li Y, Zhang G, Ng TB, Wang H. A novel lectin with antiproliferative and HIV-1 reverse transcriptase inhibitory activities from dried fruiting bodies of the monkey head mushroom Hericium erinaceum. J Biomed Biotechnol 2010; 2010: 716515.
[97]
bao ML, yang XB, Huang M, Sun L, Yang Q, Chen Y. Adjuvant effects mediated by the carbohydrate recognition domain of Agrocybe aegerita lectin interacting with avian influenza H9N2 viral surface glycosylated proteins. J Zhejiang Univ Sci B 2017; 18(8): 653-1.
[106]
Chaturvedi VK, Agarwal S, Gupta KK, Ramteke PW, Singh MP. Medicinal mushroom: boon for therapeutic applications. 3 Biotech 2018; 8(8): 1-20.
[119]
Li DF, Feng L, Hou YJ, Liu W. The expression, purification and crystallization of a ubiquitin-conjugating enzyme E2 from Agrocybe aegerita underscore the impact of His-tag location on recombinant protein properties. Acta Crystallogr Sect F Struct Biol Cryst Commun 2013; 69(Pt 2): 153-7.
[156]
Shin HH, Choi HS. Purification and partial characterization of a metalloprotease in flammulina velutipes. J Microbiol 1998; 36(1): 20-5.
[167]
Wong JH, Ng TB, Jiang Y, Liu F, Zhang SCWS. Purification and characterization of a laccase with inhibitory activity toward HIV-1 reverse transcriptase and tumor cells from an edible mushroom (Pleurotus cornucopiae). Prot & Pept Lett 2010; 17: 1040-7.
[169]
Zhao S, Rong CB, Kong C, Liu Y, Xu F, Miao QJ, et al. A novel laccase with potent antiproliferative and HIV-1 reverse transcriptase inhibitory activities from mycelia of mushroom Coprinus comatus. Biomed Res Int 2014; 2014
[171]
de Faria RO, Moure VR, de Almeida Amazonas MAL, Krieger N, Mitchell DA. The biotechnological potential of mushroom tyrosinases. Food Technol Biotechnol 2007; 45(3): 287-94.
[189]
Ni H, Li L, Liu G, Hu SQ. Inhibition mechanism and model of an angiotensin I-converting enzyme (ACE)-inhibitory hexapeptide from yeast (Saccharomyces cerevisiae). PLoS One 2012; 7(5): e37077.
[202]
Zhang M, Zhang Y, Zhang L, Tian Q. Mushroom polysaccharide lentinan for treating different types of cancers: A review of 12 years clinical studies in China.Prog Mol Biol Trans Sci. (1st ed.). Elsevier Inc. Amsterdam 2019; 163: pp. 297-328.